Skip to content

Category: Neurological DisordersSyndicate content

Early protein processes crucial to formation and layering of myelin membrane

November 24, 2009

Chestnut Hill, Mass. (11/24/2009) -- New findings from an international team of researchers probing the nerve-insulating myelin sheath were bolstered by the work of Boston College biologists, who used x-rays to uncover how mutations affect the structure of myelin, a focal point of research in multiple sclerosis and other neurological disorders.

New understanding about mechanism for cell death after stroke leads to possible therapy

November 22, 2009

Scientists at the Brain Research Centre, a partnership of the University of British Columbia Faculty of Medicine and Vancouver Coastal Health Research Institute, have uncovered new information about the mechanism by which brain cells die following a stroke, as well as a possible way to mitigate that damage. The results of the study were recently published online in Nature Medicine.

Possible link studied between childhood abuse and early cellular aging

November 20, 2009

PROVIDENCE, R.I. [Brown University] -- Children who suffer physical or emotional abuse may be faced with accelerated cellular aging as adults, according to new research from Butler Hospital and Brown University.

On your last nerve: NC State researchers advance understanding of stem cells

November 17, 2009

Researchers from North Carolina State University have identified a gene that tells embryonic stem cells in the brain when to stop producing nerve cells called neurons. The research is a significant advance in understanding the development of the nervous system, which is essential to addressing conditions such as Parkinson's disease, Alzheimer's disease and other neurological disorders.

Children with autism show slower pupil responses, MU study finds

November 11, 2009

COLUMBIA, Mo. -- Autism affects 1 in 150 children today, making it more common than childhood cancer, juvenile diabetes and pediatric AIDS combined.

Teenage obesity linked to increased risk of MS

November 9, 2009

ST. PAUL, Minn.

Clinical tests begin on medication to correct Fragile X defect

November 2, 2009

NIH-supported scientists at Seaside Therapeutics in Cambridge, Mass., are beginning a clinical trial of a potential medication designed to correct a central neurochemical defect underlying Fragile

Unlocking mysteries of the brain with PET

October 30, 2009

Inflammatory response of brain cells -- as indicated by a molecular imaging technique -- could tell researchers more about why certain neurologic disorders, such as migraine headaches and psychosis in

Cholesterol-lowering medicines may be effective against cancer

October 27, 2009

Millions of people around the world use medicines based on statins to lower their blood cholesterol, but new research from the University of Gothenburg, published in the prestigious journal PNAS, s

Looking for the origins of music in the brain

October 20, 2009

CHICAGO--Music serves as a natural and non-invasive intervention for patients with severe neurological disorders to promote long-term memory, social interaction and communication. However, there is currently no plausible explanation of its neural basis for why and how music affects physical and psychosocial responses.

Exon-skipping drug prevents muscle wasting, maintains muscle function in dystrophin deficient mice

October 20, 2009

Oxford, United Kingdom & Bothell, WA, USA -- October 20, 2009 -- An exon skipping PPMO has demonstrated dramatic effects in the prevention and treatment of severely affected, dystrophin and utrophin-deficient mice, preventing severe deterioration of the treated animals and extending their lifespan.

Cell death occurs in the same way in plants, animals and humans

October 13, 2009

Research has previously assumed that animals and plants developed different genetic programs for cell death.

LSUHSC's England plays key role in developing new ALS treatment guidelines

October 12, 2009

New Orleans, LA -- Dr. John England, Professor and Chairman of Neurology at LSU Health Sciences Center New Orleans, analyzed research findings and was responsible for the quality and accuracy of evidence analysis and the conclusions of the studies resulting in new guidelines for treating Lou Gehrig's disease, or amyotropic lateral sclerosis (ALS).

Investment in Parkinson's disease data bank yields potential therapy

October 12, 2009

Individuals with Parkinson's disease who have higher levels of a metabolite called urate in their blood and in cerebrospinal fluid (CSF) have a slower rate of disease progression, according to a study funded by the National Institutes of Health.

Rochester-led Parkinson's study pays off again, 2 decades later

October 12, 2009

Parkinson disease progresses more slowly in patients who have higher levels of urate, a chemical that at very high level is associated with gout, scientists have found.



About us

Science Blog was started in August 2002. It lives, breathes and eats press releases from research organizations around the globe. Most of what you read here are press releases from the outfits named in the stories themselves. Got a news story you think belongs here? Let's talk. The other half of the equation is blog posts from readers like you. So if you have an interest in science, please register and join others like you in an ongoing, vibrant dialog about what makes the world tick. Meantime, please take a minute to read our Privacy Policy and Site Disclaimer.